Snapshots and ensembles of BTK and cIAP1 protein degrader ternary complexes
Abstract
Heterobifunctional chimeric degraders are a class of ligands that recruit target proteins to E3 ubiquitin ligases to drive compound-dependent protein degradation. Advancing from initial chemical tools, protein degraders represent a mechanism of growing interest in drug discovery. Critical to the mechanism of action is the formation of a ternary complex between the target, degrader and E3 ligase to promote ubiquitination and subsequent degradation. However, limited insights into ternary complex structures exist, including a near absence of studies on one of the most widely co-opted E3s, cellular inhibitor of apoptosis 1 (cIAP1). In this work, we use a combination of biochemical, biophysical and structural studies to characterize degrader-mediated ternary complexes of Bruton's tyrosine kinase and cIAP1. Our results reveal new insights from unique ternary complex structures and show that increased ternary complex stability or rigidity need not always correlate with increased degradation efficiency.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
BTK has been the subject of intense PROTAC molecule experimentation across academia and industry.
“and has been the subject of intense PROTAC molecule experimentation across academia and industry166–168”
From PROTAC targeted protein degraders: the past is prologue (2022) · cites this paper as [166]
The citation lists haven’t been fetched yet
References 61 · Cited by 113
- Authors
- Schiemer, J., Horst, R., Meng, Y., Montgomery, J. I., Xu, Y., Feng, X., Borzilleri, K., Uccello, D. P., Leverett, C., Brown, S., Che, Y., Brown, M. F., Hayward, M. M., Gilbert, A. M., Noe, M. C., & Calabrese, M. F.
- Affiliations
- Pfizer (United States) (US)
- Corresponding author
- Calabrese, Matthew F.
- ORCID
- Venue
- Nature Chemical Biology
- Published
- 2020-11-16
- Volume
- 17
- Issue
- 2
- Pages
- 152-160
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W3100538750
- Cited by
- 113
- References
- 61
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 20 · 2023: 19 · 2022: 21 · 2021: 13 · 2020: 1
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chemical Synthesis and Analysis
- Keywords
- Bruton's tyrosine kinase, cIAP1, protein degraders, ternary complex, E3 ubiquitin ligase, ubiquitination, protein degradation, ternary complex stability, degradation efficiency
- MeSH terms
- Agammaglobulinaemia Tyrosine Kinase, Chromatography, Gel, Cross-Linking Reagents, Humans, Kinetics, Models, Molecular, Protein Conformation, X-Ray Diffraction, Nuclear Magnetic Resonance, Biomolecular, Spectrometry, Mass, Electrospray Ionization, Ubiquitin-Protein Ligases, Inhibitor of Apoptosis Proteins, Ubiquitination, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review